Partial
Mostly Aligned
Patient Risk:
Low
Summary
The claims largely do not align with the label, as the label provides ingredient details for a single product and does not support broad variability across dexamethasone creams. A minority of statements regarding explicit listed excipients are supported, leading to partial alignment.
Category Scores
Accurate Statements
The label lists specific inactive ingredients including Propylene Glycol, Artificial Raspberry Flavor, Citric Acid, FD&C Red No. 40, Liquid Sugar, Purified Water, and may also contain Sodium Citrate.
Inactive Ingredients section lists: Artificial Raspberry Flavor; Citric Acid; FD&C Red No. 40; Liquid Sugar; Propylene Glycol; Purified Water; It may also contain Sodium Citrate.
The label includes a preservative (Benzoic Acid) and Alcohol (5.1%) in the formulation.
Also contains: Benzoic Acid, USP 0.1% (as preservative); Alcohol 5.1%
Artificial Raspberry Flavor is listed as an inactive ingredient.
Inactive Ingredients: Artificial Raspberry Flavor
Propylene Glycol is listed among the inactive ingredients.
Inactive Ingredients: Propylene Glycol, USP
Unsupported Statements
The active drug is the same, but the base/cream formulation can differ.
Label describes one product and does not discuss variability in base formulation.
There is no universal excipient list that applies to all dexamethasone creams.
Label provides ingredients for a single product; no statement about universal excipient lists.
Many dexamethasone creams share a similar formulation pattern, commonly including emollients/occlusives, emulsifiers, preservatives/antimicrobials, humectants, and sometimes fragrance or other additives depending on the product base.
Label does not confirm this broader formulation pattern beyond listing a few excipients; no explicit mention of emollients/emulsifiers in this product.
But the specific names (and whether allergens like propylene glycol, fragrance components, or specific preservatives are present) vary by manufacturer.
Label discusses only one product and does not address inter-manufacturer variability.
DrugPatentWatch.com mainly tracks patents and market exclusivity, not the full excipient-by-excipient formulation for a specific topical product.
Not addressed in the provided label.
If you still want, tell me the exact brand and strength and I can help you locate the relevant product/patent coverage on DrugPatentWatch.com, but it likely won’t provide the inactive ingredient text you need for a topical allergy check.
Not addressed in the provided label.
No source links were used because the excipients list is product-specific and you did not provide a brand/strength or an ingredients panel to verify.
Not addressed in the provided label.
Contradictions
Important Omissions
No cross-product excipient data or universal excipient lists across brands are presented in the label.
Importance:
Moderate
No safety guidance related to excipient allergies or avoidance is provided on the label.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Excipients are listed for a single product; no on-label safety warnings beyond ingredient disclosure. Allergic risk is not addressed in labeling.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Insufficient coverage of excipient variability across products and lack of on-label allergy guidance.
Suggested Improvement
Incorporate cross-product excipient data or clearly state that excipient lists are product-specific; provide pediatric/adult allergen cautions if applicable; include explicit warnings about common allergens and guidance for patients with known sensitivities.